Assembly Biosciences P/E Ratio

Assembly Biosciences's p/e ratio stands at 54.18. That is above the Healthcare sector average of 24.78. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Assembly Biosciences sits higher the Healthcare benchmark (24.78) with a P/E ratio of 54.18. That is roughly 118.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

Whether 54.18 is attractive depends on Assembly Biosciences's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.

The history chart shows how Assembly Biosciences's P/E ratio evolved across reporting periods, while the comparison chart places ASMB next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Assembly Biosciences's reading of 54.18 (sector avg 24.78) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.